Transcranial stimulation device and method based on electrophysiological testing

1. A neuromodulation therapy method comprising:

receiving brain value measurements and body value measurements relating to a patient;

electronically analyzing the brain value measurements and body value measurements relative to reference data generated based on machine learning operations associated with existing patient data and reference database data;

based thereon, electronically determining, using at least one processing device, a brain malady and a severity value, for the patient; and

electronically generating a treatment protocol for the patient based at least on the brain malady and the severity value, wherein the treatment protocol includes a voltage strength level, a duration, and position factors for transcranial sensors providing neurostimulation to the patient.

2. The method of claim 1 further comprising:

applying a transcranial stimulation to the patient based on the treatment protocol.

3. The method of claim 2 further comprising:

after applying the transcranial stimulation to the patient, acquiring secondary brain value measurements and secondary body value measurements;

electronically analyzing the secondary brain value measurements and secondary body value measurements in reference to the reference data; and

electronically determining a change value for the patient relative to the brain malady and severity value.

4. The method of claim 3 further comprising:

generating an updated treatment protocol for the patient based on the electronic analysis of the secondary brain value measurements and secondary body value measurements.

5. The method of claim 1 further comprising:

the brain value measurements include first electrophysiological values obtained from a brain of the patient using at least one EEG electrode; and

the body value measurements include second electrophysiological values obtained from the patient including at least one of: an electrocardiograph electrode connected to the patient and force plate measurements measuring task and balance conditions of the patient.

6. The method of claim 1 , wherein the brain malady includes at least one of: Alzheimer's, dementia, depression, mild cognitive impairment, and subjective cognitive impairment.

7. The method of claim 6 , wherein the severity value assesses an accuracy level of the brain malady of the patient.

8. The method of claim 1 , wherein the body value measurements include at least one of: a blood content value and a brain processing speed value.

9. The method of claim 1 , wherein the electronic analysis of the brain value measurements and the body value measurements includes using source localization models to isolate voxels within a brain of the patient to detect at least one region of the brain of the patient affected by the brain malady.

10. The method of claim 9 , wherein the electronic analysis includes referencing at least one brain mapping library.

11. The method of claim 1 , wherein the reference data is generated based on machine learning processing operations and deep learning processing operations executed within at least one neural network.

12. A neuromodulation therapy method comprising:

receiving brain value measurements and body value measurements relating to a patient;

electronically analyzing the brain value measurements and body value measurements relative to reference data generated based on machine learning operations associated with existing patient data and reference database data;

based thereon, electronically determining, using at least one processing device, a brain malady and a severity value, for the patient;

electronically generating a treatment protocol for the patient based at least on the brain malady and the severity value,

applying a transcranial stimulation to the patient based on the treatment protocol;

after applying the transcranial stimulation to the patient, acquiring secondary brain value measurements and secondary body value measurements;

electronically analyzing the secondary brain value measurements and secondary body value measurements in reference to the reference data; and

electronically determining a change value for the patient relative to the brain malady and severity value.

13. The method of claim 12 , wherein the treatment protocol includes a voltage strength level, a duration, and position factors for transcranial sensors providing neurostimulation to the patient.

14. The method of claim 12 further comprising:

generating an updated treatment protocol for the patient based on the electronic analysis of the secondary brain value measurements and secondary body value measurements.

15. The method of claim 12 further comprising:

the brain value measurements include first electrophysiological values obtained from a brain of the patient using at least one EEG electrode; and

the body value measurements include second electrophysiological values obtained from the patient including at least one of: an electrocardiograph electrode connected to the patient and force plate measurements measuring task and balance conditions of the patient.

16. The method of claim 12 , wherein the brain malady includes at least one of: Alzheimer's, dementia, depression, mild cognitive impairment, and subjective cognitive impairment.

17. The method of claim 12 , wherein the severity value assesses an accuracy level of the brain malady of the patient.

18. The method of claim 12 , wherein the body value measurements include at least one of: a blood content value and a brain processing speed value.

19. The method of claim 12 , wherein the electronic analysis of the brain value measurements and the body value measurements includes using source localization models to isolate voxels within a brain of the patient to detect at least one region of the brain of the patient affected by the brain malady.